Skip to content

SUPERNUS PHARMACEUTICALS, INC.

Delisted

CIK 1356576fmd_1YB15T5FAH2DM8Q9HRQY1KV5WXManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2026, 64 periods

Latest annual · FY2025

Millions
Total revenues
719
Gross profit
644
Operating income
(62)
Net income
(39)
Free cash flow
46

Latest quarter · Q3 FY2026

Millions
Total revenues
227
Gross profit
200
Operating income
21
Net income
21
Free cash flow
6
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2022 to FY2025
+2.5%
Revenue, 5 yearsFY2020 to FY2025
+6.7%
Net income, 5 yearsFY2020 to FY2025
n/m

SUPERNUS PHARMACEUTICALS, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue$719 million$661.8 million+8.6%10-K 2026-03-02 · proof
Gross profit$644.4 million$583.9 million+10.4%10-K 2026-03-02 · proof
Operating income-$62.3 million$81.7 million-176.3%10-K 2026-03-02 · proof
Net income-$38.6 million$73.9 million-152.2%10-K 2026-03-02 · proof
Cash from operating activities$47.3 million$172 million-72.5%10-K 2026-03-02 · proof
Free cash flow$46 million$171.2 million-73.1%10-K 2026-03-02 · proof
Total assets$1.5 billion$1.4 billion+6.2%10-K 2026-03-02 · proof
Total liabilities$390.9 million$332.3 million+17.6%10-K 2026-03-02 · proof
Cash and cash equivalents$128.4 million$69.3 million+85.3%10-K 2026-03-02 · proof
What was SUPERNUS PHARMACEUTICALS, INC.'s revenue in fiscal 2025?
SUPERNUS PHARMACEUTICALS, INC. reported revenue of $719 million for fiscal 2025 (the year ended Dec 31, 2025), against $661.8 million the year before (+8.6%). Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
What was SUPERNUS PHARMACEUTICALS, INC.'s gross profit in fiscal 2025?
SUPERNUS PHARMACEUTICALS, INC. reported gross profit of $644.4 million for fiscal 2025 (the year ended Dec 31, 2025), against $583.9 million the year before (+10.4%). Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
What was SUPERNUS PHARMACEUTICALS, INC.'s operating income in fiscal 2025?
SUPERNUS PHARMACEUTICALS, INC. reported operating income of -$62.3 million for fiscal 2025 (the year ended Dec 31, 2025), against $81.7 million the year before (-176.3%). Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
What was SUPERNUS PHARMACEUTICALS, INC.'s net income in fiscal 2025?
SUPERNUS PHARMACEUTICALS, INC. reported net income of -$38.6 million for fiscal 2025 (the year ended Dec 31, 2025), against $73.9 million the year before (-152.2%). Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
What was SUPERNUS PHARMACEUTICALS, INC.'s cash from operating activities in fiscal 2025?
SUPERNUS PHARMACEUTICALS, INC. reported cash from operating activities of $47.3 million for fiscal 2025 (the year ended Dec 31, 2025), against $172 million the year before (-72.5%). Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
What was SUPERNUS PHARMACEUTICALS, INC.'s free cash flow in fiscal 2025?
SUPERNUS PHARMACEUTICALS, INC. reported free cash flow of $46 million for fiscal 2025 (the year ended Dec 31, 2025), against $171.2 million the year before (-73.1%). Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
What are SUPERNUS PHARMACEUTICALS, INC.'s total assets?
As of Dec 31, 2025, SUPERNUS PHARMACEUTICALS, INC. reported total assets of $1.5 billion, against $1.4 billion a year earlier (+6.2%). Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
What are SUPERNUS PHARMACEUTICALS, INC.'s total liabilities?
As of Dec 31, 2025, SUPERNUS PHARMACEUTICALS, INC. reported total liabilities of $390.9 million, against $332.3 million a year earlier (+17.6%). Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
What are SUPERNUS PHARMACEUTICALS, INC.'s cash and cash equivalents?
As of Dec 31, 2025, SUPERNUS PHARMACEUTICALS, INC. reported cash and cash equivalents of $128.4 million, against $69.3 million a year earlier (+85.3%). Source: the 10-K filed with the SEC on Mar 2, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1356576&period_type=annual&limit=5"

Information only, not investment advice.